Botulinum Toxin A for Post-Arthroplasty Complications: A Systematic Review of Efficacy and Safety in TKA and THA

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 28

فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_TABO-14-11_002

تاریخ نمایه سازی: 22 آبان 1405

چکیده مقاله:

Objectives: To systematically review and synthesize available human studies investigating the efficacy and safety of botulinum neurotoxin type A (BoNT/A) injections for managing complications following total knee arthroplasty (TKA) and total hip arthroplasty (THA). Methods: A systematic search of Medline/PubMed, Web of Science, Scopus, and Embase was conducted up to May ۲۰۲۵ per PRISMA ۲۰۲۰ guidelines. Eligible studies enrolled adults who had undergone THA or TKA and received ≥۵۰ units (U) of intra-articular or intramuscular BoNT/A for postoperative pain, stiffness, or musculoskeletal dysfunction. The assessed outcomes included range of motion (ROM), pain scores measured using the Visual Analog Scale (VAS) or Numeric Rating Scale (NRS), functional scores including the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Harris Hip Score (HHS), Knee Society Score (KSS), and adverse events. Results: Thirteen studies met the inclusion criteria, including two RCTs and eleven case studies, with a total of ۹۲ patients. In patients undergoing TKA, BoNT/A was primarily injected into hamstring or gastrocnemius muscles, with doses from ۵۰ to ۴۰۰ U. Improvements in ROM, KSS, and pain scores were reported in most studies, though statistical significance was inconsistent. In patients undergoing THA, BoNT/A injected into hip adductors, iliopsoas, and tensor fascia lata was associated with reduced flexion contractures and pain, and improved HHS and ODI. No major adverse events were reported; minor effects included bruising and flu-like symptoms. Conclusion: BoNT/A injections appear to be safe and may be effective for managing chronic pain and flexion contractures following TKA and THA. However, heterogeneity in study design, small sample sizes, limited controls, and variable outcome measures limit the strength of the current evidence. Further high-quality randomized controlled trials are required to establish optimal dosing, timing, injection sites, and to confirm the clinical benefits of BoNT/A in this population. Level of evidence: III

نویسندگان

- -

School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

- -

Orthopedic Smart-technologies Research Lab, Tehran University of Medical Sciences, Tehran, Iran - Department of Orthopedic Surgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

- -

Student Research Committee, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran

- -

Hospital Vithas Las Palmas, Las Palmas de Gran Canaria, Las Palmas, Spain

- -

Consultant Orthopaedic Surgeon Melbourne Orthopaedic Group (MOG), Melbourne, Australia - Monash University, Department of Surgery, School of Clinical Sciences, Melbourne, Australia

- -

Orthopedic Smart-technologies Research Lab, Tehran University of Medical Sciences, Tehran, Iran - Department of Orthopedic Surgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

- -

Orthopedic Smart-technologies Research Lab, Tehran University of Medical Sciences, Tehran, Iran - Department of Orthopedic Surgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Zhang AR, Cheng QH, Yang YZ, Yang X, Zhang ZZ, ...
  • Cohen JS, Gu A, Lopez NS, Park MS, Fehring KA, ...
  • Wang C, Xu B, Wang P, et al. Association of ...
  • Frost G, Finlayson H, Saeidiborojeni S, Lagnau P, Reebye R. ...
  • Cheuy VA, Foran JRH, Paxton RJ, Bade MJ, Zeni JA, ...
  • Seyler TM, Smith BP, Marker DR, et al. Botulinum neurotoxin ...
  • Will E, Magill N, Arnold R, et al. Preoperative botulinum ...
  • Hsu PC, Wu WT, Han DS, Chang KV. Comparative Effectiveness ...
  • Yang Y, Li G, Su Y. Intraarticular botulinum toxin type ...
  • Smith EB, Shafi KA, Greis AC, Maltenfort MG, Chen AF. ...
  • Bertoni M, Castagna A, Baricich A, Berti G, Lazzaretti S, ...
  • Seyler TM, Marker DR, Bhave A, et al. Functional problems ...
  • Eibach S, Krug H, Lobsien E, Hoffmann KT, Kupsch A. ...
  • Bhave A, Zywiel MG, Ulrich SD, et al. Botulinum toxin ...
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA ...
  • Sterne JAC, Savović J, Page MJ, et al. RoB ۲: ...
  • Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality ...
  • Singh JA, Mahowald ML, Noorbaloochi S. Intraarticular botulinum toxin A ...
  • Cheesman QT, Ponzio DY, Thalody HE, Lau VW, Post ZD, ...
  • Vahedi H, Khlopas A, Szymczuk VL, Peterson MK, Hammouda AI, ...
  • Shah SN, Hornyak J, Urquhart AG. Flexion contracture after total ...
  • Singh JA. Efficacy of Long-term Effect and Repeat Intraarticular Botulinum ...
  • Santamato A, Ranieri M, Panza F, et al. Botulinum toxin ...
  • Fish DE, Chang WS. Treatment of iliopsoas tendinitis after a ...
  • Mitsuyasu H, Matsuda S, Miura H, Okazaki K, Fukagawa S, ...
  • Hajimirzaei SM, Cham MB, Dolikhani M, Tabatabaee SM, Ebrahimpour A.The ...
  • Khoshrang H, Haghighi M, Atrkarroushan Z, Hemmati S, Azizi R. ...
  • Parsa A, Esmaeilian S, Anz AW, et al. The Efficacy ...
  • نمایش کامل مراجع